BSE Circulars (8166)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE demat auction listing for settlement 681 dated July 28, 2025, containing 83 securities across various sectors. | |||||||||||||||
BSE demat auction listing for settlement 681 dated July 28, 2025, containing 83 securities across various sectors.
| |||||||||||||||
BSE demat auction listing 82 securities with specified quantities for settlement on July 28, 2025. | |||||||||||||||
BSE demat auction listing 82 securities with specified quantities for settlement on July 28, 2025.
| |||||||||||||||
BSE announces demat auction for settlement 681 covering 84 scrips with specified quantities for auction. | |||||||||||||||
BSE announces demat auction for settlement 681 covering 84 scrips with specified quantities for auction. | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective July 29, 2025. | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective July 29, 2025.
| |||||||||||||||
BSE announces addition of new securities to Enhanced Surveillance Measure framework and movement of existing securities to higher stages … | |||||||||||||||
BSE announces addition of new securities to Enhanced Surveillance Measure framework and movement of existing securities to higher stages effective July 29, 2025.
| |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective July 29, 2025. | |||||||||||||||
BSE updates Enhanced Surveillance Measure framework with new securities additions and stage movements effective July 29, 2025.
| |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies. | |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies.
| |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies. | |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies.
| |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies. | |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies.
| |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies. | |||||||||||||||
Eiko Lifesciences Ltd has forfeited 1,39,591 partly paid-up equity shares due to non-payment of allotment/call monies.
| |||||||||||||||